• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [21959 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Darunavir-cobicistat-emtricitabine-tenofovir alafenamide (HIV infection) - Benefit assessment according to §35a Social Code Book V]
2017     NIHR Health Technology Assessment programme A systematic review and economic evaluation of adalimumab and dexamethasone for treating non-infectious intermediate uveitis, posterior uveitis or panuveitis in adults
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Antibodies to pgp9.5 in small fiber neuropathy]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Dimethyl fumarate (psoriasis) - Benefit assessment according to §35a Social Code Book V]
2017     NIHR Health Technology Assessment programme Assessing the performance of methodological search filters to improve the efficiency of evidence information retrieval: five literature reviews and a qualitative study
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Ketoanalogue diet for advanced chronic kidney failure]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Atezolizumab (urothelial carcinoma, first-line treatment) - Benefit assessment according to §35a Social Code Book V]
2017     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness results from the randomised, Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare fludarabine, cyclophosphamide and rituximab with fludarabine, cyclophosphamide, mitoxantrone and low-dose rituximab: the Attenuated dose Rituximab with ChemoTherapy In Chronic lymphocytic leukaemia (ARCTIC) trial
2017     NIHR Health Technology Assessment programme Facet-joint injections for non-specific low back pain: a feasibility RCT
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Biologics in patients with spondyloarthritis]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Atezolizumab (urothelial carcinoma) - Benefit assessment according to §35a Social Code Book V]
2017     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of a multifaceted podiatry intervention for falls prevention in older people: a multicentre cohort randomised controlled trial (the REducing Falls with ORthoses and a Multifaceted podiatry intervention trial)
2017     NIHR Health Technology Assessment programme Self-management toolkit and delivery strategy for end-of-life pain: the mixed-methods feasibility study
2017     Basque Office for Health Technology Assessment (OSTEBA) [Clinical Practice Guideline about breastfeeding]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Stereotactic body radiation therapy in pancreatic cancer]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Atezolizumab (non-small cell lung cancer) - Benefit assessment according to §35a Social Code Book V]
2017     NIHR Health Technology Assessment programme Virtual chromoendoscopy for the real-time assessment of colorectal polyps in vivo: a systematic review and economic evaluation
2017     Basque Office for Health Technology Assessment (OSTEBA) [Guide for breastfeeding mother. Guide for women who wish to breastfeed or who breastfeed, as well as their partners and family]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Complete exome sequencing in epileptic encephalopathy]
2017     NIHR Health Technology Assessment programme Surveillance versus ablation for incidentally diagnosed small renal tumours: the SURAB feasibility RCT
2017     Basque Office for Health Technology Assessment (OSTEBA) [Clinical practice guidelines on lipid management as a cardiovascular risk factor]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Endoscopic surgery in patients with middle ear conditions]
2017     HAYES, Inc. Acclarent eustachian tube balloon dilation for the treatment of eustachian tube dysfunction inadults
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Dinutuximab for patients with high-risk neuroblastoma]
2017     HAYES, Inc. Bielfeld eustachian tube balloon dilation for the treatment of chronic eustachian tube dysfunction in adults
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Tearlab® osmolarity system for dry eye]
2017     HAYES, Inc. Buprenorphine extended-release implant (Probuphine; Braeburn Pharmaceuticals Inc.) for opioid use disorder
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Preimplantational genetic diagnosis (pgt-a) in assisted reproduction technologies]
2017     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening for hepatitis C virus: a systematic review
2017     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Home use of a mechanical cough-assist insufflation-exsufflation device for adults with neuromuscular diseases who do not require ventilatory support]
2017     NIHR Health Technology Assessment programme Development and validation of Prediction models for Risks of complications in Early-onset Pre-eclampsia (PREP): a prospective cohort study
2017     HAYES, Inc. Impella CP (Abiomed) for use in adult patients with cardiogenic shock
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [HD Analyzer® in cataract and dry eye]
2017     HAYES, Inc. Noncontact low-frequency ultrasound using the MIST Therapy System (Celleration Inc.) for treatment of venous leg ulcers
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Infrared meibography for meibomian gland disease]
2017     Canadian Agency for Drugs and Technologies in Health (CADTH) Interventions for the treatment of obstructive sleep apnea in adults: a health technology assessment
2017     HAYES, Inc. Peripheral nerve ablation for treatment of osteoarthritic knee pain
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Prosthesis replacement in ankle osteoarthritis]
2017     NIHR Health Technology Assessment programme CollAborative care for Screen-Positive EldeRs with major depression (CASPER plus): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness
2017     HAYES, Inc. Propel and propel mini bioabsorbable steroid-releasing sinus implants for treatment of chronic rhinosinusitis in adults
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [CYD tetravalent dengue vaccine]
2017     NIHR Health Technology Assessment programme Prevention and treatment of long-term social disability amongst young people with emerging severe mental illness with social recovery therapy (The PRODIGY Trial): study protocol for a randomised controlled trial
2017     HAYES, Inc. EndoPredict (Myriad Genetics)
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Ulipristal in uterine myomatosis]
2017     HAYES, Inc. The prostate health index for prebiopsy triage (Beckman Coulter)
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Platelet-rich plasma in diabetic foot ulcers]
2017     HAYES, Inc. Adoptive immunotherapy using genetically modified lymphocytes for lymphoproliferative disorders or hematological malignancies
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Lung cryobiopsy in diffuse interstitial lung disease diagnosis]
2017     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Cost-effective imaging for resectability of liver lesions in colorectal cancer: an economic decision model
2017     HAYES, Inc. Cognitive rehabilitation therapy for traumatic brain injury (TBI)
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Dual target deep brain stimulation in refractory dystonia]
2017     NIHR Health Technology Assessment programme Cognitive-behaviour therapy for health anxiety in medical patients (CHAMP): a randomised controlled trial with outcomes to 5 years
2017     HAYES, Inc. Comparative effectiveness of endovenous laser therapy versus conventional surgery for symptomatic varicose veins: a review of reviews
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Lutetium-177 radiolabeled somatostatin analogs in neuroendocrine tumors]
2017     NIHR Health Technology Assessment programme Spot protein-creatinine ratio and spot albumin-creatinine ratio in the assessment of pre-eclampsia: a diagnostic accuracy study with decision-analytic model-based economic evaluation and acceptability analysis
2017     HAYES, Inc. Comparative effectiveness of Roux-en-Y gastric bypass and sleeve gastrectomy for treatment of type ii diabetes: a review of reviews
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Platelet-rich plasma in orthopedic diseases]
2017     HAYES, Inc. Comparative effectiveness review of cryoablation for primary treatment of localized prostate cancer
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Platelet-rich plasma in maxillofacial surgery]
2017     HAYES, Inc. Comparative effectiveness review of cryoablation for salvage treatment of recurrent prostate cancer following radiotherapy
2017     Basque Office for Health Technology Assessment (OSTEBA) [Guide on Prader-Willi Syndrome. Guide to health personnel for the adequate knowledge and management of a rare disease called Prader-Willi Syndrome]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Induced sputum in severe asthma patients]
2017     NIHR Health Technology Assessment programme Developing a multidisciplinary rehabilitation package following hip fracture and testing in a randomised feasibility study: Fracture in the Elderly Multidisciplinary Rehabilitation (FEMuR)
2017     HAYES, Inc. Comparative effectiveness review of first-generation autologous chondrocyte implantation of the knee
2017     Basque Office for Health Technology Assessment (OSTEBA) [Effectiveness of non-invasive mechanical ventilation for the treatment of respiratory failure in patients with amyotrophic lateral sclerosis]
2017     HAYES, Inc. Comparative effectiveness review of paravertebral block for prevention of chronic pain after breast surgery
2017     Basque Office for Health Technology Assessment (OSTEBA) [Online hemodiafiltration: evaluation of its safety, effectiveness, cost and usage indications]
2017     NIHR Health Technology Assessment programme Start2quit: a randomised clinical controlled trial to evaluate the effectiveness and cost-effectiveness of using personal tailored risk information and taster sessions to increase the uptake of the NHS Stop Smoking Services
2017     HAYES, Inc. Comparative effectiveness review of robotically assisted hysterectomy
2017     Basque Office for Health Technology Assessment (OSTEBA) [ATOMs – Adjustable Transobturator Male System. Device for urinary incontinence]
2017     Agency for Healthcare Research and Quality (AHRQ) Supplemental project to assess the transparency of reporting requirements for studies evaluating the effectiveness of treatment options for symptoms of diabetic peripheral neuropathy
2017     HAYES, Inc. Comparative effectiveness review of second- and third-generation autologous chondrocyte implantation of the knee
2017     Basque Office for Health Technology Assessment (OSTEBA) [Endoscopic mucosal resection (EMR) and endoscopic mucosal dissection (EMD) in superficial gastrointestinal tumors]
2017     HAYES, Inc. Comparative effectiveness review of single-level artificial disc replacement for cervical degenerative disc disease
2017     Basque Office for Health Technology Assessment (OSTEBA) [Analysis of the efficacy, safety and efficiency of stabilisation of intervertebral discs using Discogel]
2017     Canadian Agency for Drugs and Technologies in Health (CADTH) Treatments for locally advanced oropharyngeal cancer: a systematic review of clinical effectiveness and cost-effectiveness
2017     HAYES, Inc. Comparative effectiveness review of topical antiseptic products for antisepsis prior to vascular or epidural catheter insertion
2017     Basque Office for Health Technology Assessment (OSTEBA) [Clinical effectiveness and cost-effectiveness of non-invasive telemonitoring on patients with heart failure]
2017     HAYES, Inc. Comparative effectiveness review of topical chlorhexidine gluconate for preoperative skin antisepsis
2017     Basque Office for Health Technology Assessment (OSTEBA) [Evaluation of the utility and indication of prostate biopsies with image fusion – magnetic resonance and transrectal ultrasound]
2017     Health Quality Ontario (HQO) Percutaneous ventricular assist devices: a health technology assessment
2017     HAYES, Inc. Fecal calprotectin assay for monitoring disease activity in Crohn disease
2017     Basque Office for Health Technology Assessment (OSTEBA) [Updating of the shared work system for systematic reviews of the evidence and critical appraisal (FLC 3.0 Platform)]
2017     NIHR Health Technology Assessment programme Real-time modelling of a pandemic influenza outbreak
2017     Health Quality Ontario (HQO) Patient safety learning systems: a systematic review and qualitative synthesis
2017     HAYES, Inc. Local injection therapy for cervicogenic headache and occipital neuralgia
2017     Basque Office for Health Technology Assessment (OSTEBA) [System for percutaneous replacement of mitral valve (MitraClip). Monitoring Study Protocol (1st part)]
2017     Health Quality Ontario (HQO) Pharmacogenomic testing for psychotropic medication selection: a systematic review of the Assurex GeneSight Psychotropic test
2017     HAYES, Inc. Positron emission tomography-computed tomography (PET-CT) for detection of primary site in neuroendocrine tumors of unknown origin
2017     Basque Office for Health Technology Assessment (OSTEBA) [System for percutaneous replacement of mitral valve using a Clip. Monitoring study (part 2)]
2017     Canadian Agency for Drugs and Technologies in Health (CADTH) Dual antiplatelet therapy following percutaneous coronary intervention: a review of the clinical impact of treatment duration
2017     HAYES, Inc. The clinical utility of lumbar discography for assessing low back pain: impact on patient management and health outcomes
2017     Canadian Agency for Drugs and Technologies in Health (CADTH) Proton beam therapy for the treatment of cancer in children and adults: a health technology assessment
2017     NIHR Health Technology Assessment programme A randomised controlled trial to compare the safety, effectiveness and cost effectiveness of doxycycline (200 mg/day) with oral prednisolone (0.5 mg/kg/day) for initial treatment of bullous pemphigoid: the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial
2017     NIHR Health Technology Assessment programme A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial
2017     HAYES, Inc. Transcatheter closure of prosthetic aortic or mitral paravalvular leaks
2017     Canadian Agency for Drugs and Technologies in Health (CADTH) New drugs for type 2 diabetes: second-line therapy - science report
2017     Agency for Healthcare Research and Quality (AHRQ) Glasgow Coma Scale for field triage of trauma: a systematic review
2017     HAYES, Inc. Wireless capsule systems for diagnosis of gastroparesis and monitoring of gastrointestinal motility
2017     Agency for Healthcare Research and Quality (AHRQ) Tonsillectomy for obstructive sleep-disordered breathing or recurrent throat infection in children